Vaish Unveils Low‑Cost Cirrhosis Tool, 250k Deaths

Global liver disease burden is rising, with about 250,000 annual deaths in India, highlighting a critical public‑health crisis.
Dr. Udit Bhaskar Vaish proposes using NLR and APRI indices from routine blood tests as a low‑cost tool to assess cirrhosis severity.
The methodology was accepted for podium presentation at the 24th ECIM 2026 in Vienna, drawing international attention.
Analysts expect the solution to boost sentiment for healthcare, diagnostics and pharma firms, potentially driving short‑term stock gains.